FMP

FMP

Enter

ONC.TO - Oncolytics Biotech I...

photo-url-https://images.financialmodelingprep.com/symbol/ONC.TO.png

Oncolytics Biotech Inc.

ONC.TO

TSX

Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with paclitaxel and avelumab, a human anti-PD-L1 antibody for the treatment of hormone receptor-positive/human epidermal growth factor 2-negative metastatic breast cancer; and PrECOG LLC. The company was incorporated in 1998 and is headquartered in Calgary, Canada.

0.71 CAD

-0.05 (-7.04%)

Balance Sheet

Year

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

Total Cash

31.22M

41.26M

32.14M

34.91M

15.94M

-

-

-

-

-

Total Cash %

100

100

100

100

100

100

100

100

100

Receivables

89.66k

866.05k

521k

15k

68k

-

-

-

-

-

Receivables %

100

100

100

100

100

100

100

100

100

Inventories

-

-

-

-

-

-

-

-

-

-

Inventories %

100

100

100

100

100

100

100

100

100

Payable

-

594k

2.25M

1.08M

1.09M

-

-

-

-

-

Payable %

100

100

100

100

100

100

100

100

100

Cap Ex

-29.3k

-285.95k

-55k

-8k

-239k

-

-

-

-

-

Cap Ex %

100

100

100

100

100

-

-

-

-

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2025 © Financial Modeling Prep